Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Columbia Labs

This article was originally published in The Tan Sheet

Executive Summary

Licenses rights to Replens and Feminesse products in the U.K. to Unipath, a division of Unilever. The deal includes "up-front payments for the products" to Columbia Labs and an exclusive supply agreement on future sales, Columbia said. The company also will receive additional payments if further indications are cleared by British health authorities. In the U.K., Replens is sold to treat vaginal dryness and Feminesse is marketed for the prevention of vaginal odor
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS082325

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel